Key Takeaways
- A meta-analysis of six randomized controlled trials (546 participants) found 2,000 FU daily significantly reduces systolic blood pressure by an average of 3.45 mmHg
- The largest clinical study (1,062 participants, 12 months) used 10,800 FU daily and found significant reductions in arterial plaque — but it was observational, not a randomized trial
- FU (Fibrinolytic Units) measure enzyme activity, not weight — two "100 mg" nattokinase products can have very different potencies if FU is not specified
- The Japan Nattokinase Association (JNKA) recommends 2,000 FU daily as the standard dose and requires FU-based labeling on certified products
- Safety data supports doses up to 10,800 FU daily for 12 months without adverse effects, though doses above 2,000 FU have not been tested in randomized controlled trials
- Nattokinase should not be taken with anticoagulant medications (warfarin, heparin) without medical supervision due to enhanced bleeding risk
You have a bottle of nattokinase in your hand — or you are about to buy one — and you want a simple answer: how much should you take each day? The problem is that the numbers you find online range from 2,000 FU to 10,800 FU, a fivefold difference that makes it nearly impossible to feel confident about your dose.
The confusion is understandable. Most supplement labels recommend 2,000 FU, but a widely cited clinical study used 10,800 FU and showed impressive cardiovascular results. Some sources call 2,000 FU "the standard," while others argue it falls short. Which is it?
The answer depends on what you are trying to achieve. A meta-analysis of six randomized controlled trials confirms that 2,000 FU per day reliably reduces blood pressure. A larger (but observational) study of over a thousand participants found that 10,800 FU per day reduced arterial plaque over twelve months. Different nattokinase doses per day serve different purposes — and the clinical evidence behind each dose varies in strength.
In this guide, we reviewed the published clinical research, compared findings from both international and Japanese studies, and mapped out which nattokinase dose per day matches which health goal — so you can make a decision grounded in evidence, not marketing.
Understanding Nattokinase Dosage Units
What Are Fibrinolytic Units (FU)?
Fibrinolytic Units measure nattokinase's actual biological activity — specifically, its ability to break down fibrin, the protein that forms blood clots. Unlike milligrams, which measure weight, FU tells you how potent the enzyme actually is [20].
The approximate conversion is 2,000 FU per 100 mg of nattokinase, but this ratio varies by manufacturer. A product labeled "100 mg nattokinase" without an FU specification tells you nothing about potency, because extraction and purification methods differ across producers.
FU vs Milligrams: Why It Matters
This distinction has real consequences for dosing. Consider two products:
| Product | Weight per Capsule | FU per Capsule | Actual Potency |
|---|---|---|---|
| Product A | 100 mg | 2,000 FU | Standard |
| Product B | 100 mg | Not specified | Unknown |
| Product C | 200 mg | 4,000 FU | Double standard |
If a supplement label only lists milligrams without FU, you cannot determine its potency. The Japan Nattokinase Association (JNKA) mandates FU-based labeling for certified products — a quality signal worth looking for [20]. All nattokinase products in our curated selection specify FU per serving.
When clinical studies report nattokinase doses, they use FU as the primary metric. Every dosage recommendation in this guide is expressed in FU for this reason.
Standard Nattokinase Dose: What Clinical Studies Used
The most widely studied nattokinase dose is 2,000 FU (approximately 100 mg) per day. This is the dose with the broadest evidence base and the longest safety track record.
The 2,000 FU Evidence Base
A systematic review and meta-analysis of six randomized controlled trials encompassing 546 participants found that nattokinase supplementation at doses ranging from 1,200 to 8,000 FU per day significantly reduced systolic blood pressure by an average of 3.45 mmHg, with the strongest effects in 8-week trials [1].
A randomized, double-blind, placebo-controlled, multicenter North American trial (79 participants) found that 2,000 FU daily for 8 weeks reduced diastolic blood pressure from approximately 87 to 84 mmHg and reduced von Willebrand factor, a cardiovascular risk marker [4].
An earlier study of 12 Japanese adults demonstrated that 2,000 FU daily for 2 months significantly decreased plasma fibrinogen (by 7.6%), factor VII (by 14%), and factor VIII (by 17.4%) — confirming fibrinolytic and anticoagulant effects at the standard dose [9].
An Important Caveat at Standard Doses
Not all outcomes respond to 2,000 FU. The NAPS (Nattokinase Atherothrombotic Prevention Study), a 3-year randomized controlled trial of 265 participants, found no significant effect on subclinical atherosclerosis progression at 2,000 FU daily. The authors acknowledged the dose may have been insufficient for this specific outcome [3].
This is an honest and important finding: 2,000 FU appears effective for blood pressure and fibrinolytic activity, but it may not be enough for arterial plaque management. That question leads to the higher-dose research below.
Nattokinase Dosage by Health Goal
Based on available clinical evidence, the right nattokinase dose per day depends on your specific health goal. The table below summarizes what the research supports:
| Health Goal | Evidence-Based Dose | Study Support | Evidence Level |
|---|---|---|---|
| Blood pressure support | 2,000 FU/day | Meta-analysis of 6 RCTs (n=546) [1] | Strong |
| Fibrinolytic activity (clot prevention) | 2,000 FU/day | Multiple clinical studies [9] | Strong |
| Cholesterol and lipid support | 4,000 FU/day | Post-stroke study (12 months) [2] | Moderate |
| Cardiovascular/plaque management | 10,800 FU/day | Observational study (n=1,062) [2] | Moderate (observational only) |
| General wellness and prevention | 2,000 FU/day | JNKA recommendation; most widely studied [20] | Moderate |
Choosing a nattokinase supplement? All three products in our curated selection are Japanese-manufactured with FU potency clearly labeled — including a 4,000 FU option for those targeting above-standard doses.
Blood Pressure Support: Strong Evidence
For blood pressure reduction, the evidence at 2,000 FU is the strongest in the entire nattokinase literature. The meta-analysis found a consistent systolic reduction of approximately 3.45 mmHg across multiple trials, with no notable adverse events reported [1].
If your primary goal is blood pressure support, 2,000 FU daily is the evidence-backed starting point.
Cholesterol and Lipid Support: Moderate Evidence
A study of post-stroke and transient ischemic attack patients found that 4,000 FU daily for 12 months reduced LDL cholesterol (p=0.02), though vascular event differences were not statistically significant [2]. This is the dose delivered by Japanese Nattokinase 4000, one of the products in our curated selection.
A separate randomized, double-blind, placebo-controlled trial found that nattokinase combined with red yeast rice showed synergistic effects on lipid profiles in patients with stable coronary artery disease, with no adverse events [5].
Cardiovascular and Arterial Health: The Higher-Dose Question
For arterial plaque management, the evidence points to higher doses — but with a critical caveat about study design. The next section covers this in detail.
Higher-Dose Research: The 10,800 FU Study
The largest clinical study of nattokinase to date enrolled 1,062 participants with atherosclerosis and hyperlipidemia and administered 10,800 FU daily for 12 months. Results showed significant reductions in carotid intima-media thickness, plaque size, and improvements in lipid profiles compared to a smaller comparison group receiving 3,600 FU daily. No adverse effects were reported [2].
These results are compelling, but context matters:
- This was a retrospective observational study, not a randomized controlled trial. Participants were not randomly assigned to dose groups, and there was no placebo control. This limits the strength of causal conclusions.
- The comparison group (3,600 FU) was smaller, making direct dose comparisons less reliable.
- The study authors themselves called for randomized controlled trials to confirm these findings.
- Participants were under physician supervision throughout the study period. This was not a self-directed supplementation protocol.
What this means for you: The 10,800 FU dose shows promise for cardiovascular and plaque management, but it has not been validated in the same rigorous way that 2,000 FU has been for blood pressure. If you are considering doses above 2,000 FU, discuss it with your healthcare provider. This is especially important because higher doses may amplify bleeding risk.
When and How to Take Nattokinase
Best Time of Day
No published clinical trial has directly compared morning versus evening nattokinase dosing. However, there is a physiological rationale worth considering.
The body's natural fibrinolytic (clot-dissolving) activity is lowest in the early morning hours — which is also when cardiovascular events like heart attacks and strokes are most likely to occur. Some practitioners suggest evening or bedtime dosing so that nattokinase activity peaks during this vulnerable window. This is a theoretical consideration, not a clinically proven strategy.
Most clinical trials administered nattokinase once daily without specifying time of day [1][4].
With or Without Food
Clinical trials did not consistently control for food timing. A pharmacokinetic pilot study confirmed that nattokinase is absorbed intact when taken orally and is detectable in serum, with peak activity several hours after ingestion [10]. Research in animal models indicates that nattokinase is absorbed through the small intestine via transcellular transport [11].
In the absence of definitive clinical guidance, follow the instructions on your product label.
Can You Split the Dose?
Most clinical trials used a single daily dose. There is no published evidence comparing split dosing (e.g., 1,000 FU morning + 1,000 FU evening) versus a single 2,000 FU dose. Unless your healthcare provider advises otherwise, taking your full daily dose at one time is consistent with how the research was conducted.
How Long Until You See Results
Nattokinase is not a fast-acting supplement. Based on clinical trial durations and measured endpoints, here is what the evidence shows:
| Effect | Time to Measurable Change | Study Reference |
|---|---|---|
| Blood pressure reduction | 4-8 weeks | Meta-analysis subgroup analysis; Jensen et al. RCT [1] |
| Fibrinolytic activity (fibrinogen, factor VII/VIII) | 8 weeks | Hsia et al. [9] |
| Cholesterol and lipid changes | 3-6 months | Liu et al. RCT (12 weeks); post-stroke study (12 months) [5] |
| Arterial plaque changes | ~12 months | 10,800 FU observational study [2] |
| Circulation-related symptom relief | ~30 days | Gallelli et al. vascular patient study [6] |
These timelines are based on when studies measured outcomes, not necessarily when effects begin. Individual responses will vary. Plan for at least 8 weeks of consistent daily use before evaluating whether nattokinase is working for your specific goal.
Safety Considerations
Overall Safety Profile
Nattokinase is generally well-tolerated. A systematic review of randomized controlled trials reported "no notable adverse events" across all included studies [1]. A real-world observational study of vascular disease patients confirmed no adverse events, with participant compliance exceeding 95% [6].
Toxicological assessment established a 90-day oral no-observed-adverse-effect level (NOAEL) in animal models at 1,000 mg/kg/day — orders of magnitude above human supplement doses [12].
Drug Interactions
This is the most critical safety consideration for nattokinase:
| Medication Class | Interaction | Risk Level | Action |
|---|---|---|---|
| Anticoagulants (warfarin, heparin, enoxaparin) | Nattokinase enhances fibrinolytic effects, potentially increasing bleeding risk | High | Do not combine without medical supervision. INR monitoring essential [13] |
| Antiplatelet drugs (aspirin, clopidogrel) | Additive anti-clotting action may increase bleeding risk | Moderate-High | Avoid without medical supervision [14] |
| Antihypertensives | Additive blood pressure lowering | Low-Moderate | Monitor blood pressure; dose adjustments may be needed [4] |
Who Should Avoid Nattokinase
- People with bleeding disorders or elevated bleeding risk [13]
- People taking anticoagulant or antiplatelet medications without medical oversight
- Before surgery: Discontinue at least 1-2 weeks before surgical or dental procedures [13]
- Pregnancy and nursing: Insufficient human safety data — not recommended [14]
- Soy allergy: Nattokinase is derived from soy fermentation
Maximum Safe Dose
No serious adverse effects have been reported at doses up to 10,800 FU per day for 12 months (in a study of 1,062 participants) [2]. Separately, doses of 2,000-7,000 FU daily have been used for up to 3 years without significant adverse events. Toxicological studies show a large safety margin [12].
However, safety at higher doses has only been demonstrated in observational settings, not in randomized controlled trials. The precautionary principle applies: the higher the dose, the more important medical supervision becomes — particularly regarding bleeding risk.
Realistic Expectations
Nattokinase is not a replacement for prescribed cardiovascular medications. It should be considered a complementary supplement, not a substitute for medical treatment. If you are managing a cardiovascular condition, work with your healthcare provider to determine whether and how nattokinase fits into your overall plan.
The Science Behind Japanese Nattokinase Standards
Nattokinase was discovered by Dr. Hiroyuki Sumi while researching thrombolytic agents at Chicago University. His foundational research, continued at Okayama Prefectural University, confirmed the fibrin-dissolving properties of the enzyme extracted from natto — the traditional Japanese fermented soybean food that has been part of the Japanese diet for centuries [18]. Japan has the deepest research history with this enzyme, starting decades before international interest emerged.
JNKA Certification: A Quality Signal Worth Knowing
The Japan Nattokinase Association (JNKA, 日本ナットウキナーゼ協会) has over 30 member companies and sets quality standards for nattokinase products. JNKA-certified products must meet specific criteria: FU-based potency labeling (not just milligram weight), standardized fibrinolytic activity testing, and typical certification at 2,000-5,000 FU per dose [20].
Why this matters: In markets without JNKA-equivalent oversight, nattokinase potency is self-reported by manufacturers. JNKA certification provides independent verification that the FU count on the label reflects actual enzyme activity.
The NSK-SD Innovation: Vitamin K2 Removal
Standard natto-derived nattokinase naturally contains vitamin K2, which can interfere with warfarin therapy. Japan Bio Science Laboratory (日本生物科学研究所) developed NSK-SD, a nattokinase formulation with vitamin K2 specifically removed. This addresses one of the primary drug interaction concerns and is designed for people who need to avoid vitamin K — a uniquely Japanese safety innovation [20].
Why this matters: If you take blood thinners and are considering nattokinase (with your doctor's guidance), a vitamin K2-removed formulation like NSK-SD eliminates one variable from an already complex interaction picture.
Functional Food Regulatory Framework
Several Japanese nattokinase products hold 機能性表示食品 (Foods with Function Claims) certification from Japan's Consumer Affairs Agency (消費者庁), permitting evidence-based health claims like "supports healthy blood flow." This regulatory framework requires manufacturers to submit scientific evidence for review — a more structured approach than the dietary supplement framework in many international markets [21].
Why this matters: Japanese functional food certification provides an additional layer of evidence review that goes beyond basic manufacturing quality. It signals that the health claim on the label has been evaluated against published research.
Japanese Research Context in Global Perspective
A review of functional foods with antihypertensive effects published on J-STAGE examined nattokinase alongside other Japanese functional food ingredients, noting its validated blood-pressure-lowering mechanism [19]. This kind of research — situating nattokinase within Japan's broader functional food ecosystem — provides context that international studies focused on isolated clinical endpoints do not.
Our Recommendations
Japanese Nattokinase 4000
Why We Selected This: Delivers 4,000 FU per serving — the same dose shown in clinical research to reduce LDL cholesterol over 12 months. Double the standard 2,000 FU without needing multiple capsules. Manufactured in Japan with quality standards aligned to Japanese nattokinase production heritage.
View Japanese Nattokinase 4000 →
Nattokinase EX
Why We Selected This: A cardiovascular-focused formulation designed for comprehensive heart and circulation support. From a Japanese manufacturer with specific expertise in nattokinase production. Selected for users who want nattokinase as part of a broader cardiovascular wellness approach.
Noguchi Nattokinase HQ
Why We Selected This: A premium formulation from the established Noguchi brand. Japanese-manufactured with attention to potency standardization. Selected for users who prioritize brand heritage and manufacturing quality in their supplement choices.
| Product | FU per Serving | Best For | Format |
|---|---|---|---|
| Japanese Nattokinase 4000 | 4,000 FU | Users wanting above-standard dosing | Capsules |
| Nattokinase EX | Standard | Cardiovascular-focused support | Capsules |
| Noguchi Nattokinase HQ | Standard | Premium quality, brand heritage | Capsules |
Conclusion
The right nattokinase dose per day is not a single number — it depends on your health goal and the level of evidence you are comfortable with. For blood pressure support and general cardiovascular wellness, 2,000 FU daily is the dose with the strongest clinical evidence, supported by multiple randomized controlled trials and endorsed by the Japan Nattokinase Association. For more targeted cardiovascular outcomes like plaque management, higher doses (up to 10,800 FU) show promise but rest on observational data and warrant medical supervision.
Three things matter most when choosing your dose: understanding that FU (not milligrams) is the meaningful unit, matching your dose to your specific goal, and being transparent with your healthcare provider — especially if you take medications that affect blood clotting.
Nattokinase is one of the better-studied cardiovascular supplements, with a safety profile that inspires reasonable confidence at standard doses. Start with the evidence, adjust with guidance, and give it time to work.
If you are ready to choose a supplement, our team has reviewed and selected three Japanese-manufactured nattokinase products — each with verified FU potency, from brands with established nattokinase expertise. View our nattokinase selection →
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials
- Effective management of atherosclerosis progress and hyperlipidemia with nattokinase
- Nattokinase atherothrombotic prevention study: A randomized controlled trial
- Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor
- Cardiovascular effects of nattokinase combined with red yeast rice in patients with stable coronary artery disease
- Data recorded in real life support the safety of nattokinase in patients with vascular diseases
- Research progress of nattokinase in reducing blood lipid
- The effect of Nattokinase-Monascus supplements on dyslipidemia
- Nattokinase decreases plasma levels of fibrinogen, factor VII, and factor VIII in human subjects
- A pilot study on the serum pharmacokinetics of nattokinase in humans
- Study on the transport and internalisation mechanism of dietary supplement nattokinase in the small intestine
- Toxicological assessment of nattokinase derived from Bacillus subtilis var. natto
- Nattokinase: an oral antithrombotic agent for the prevention of cardiovascular disease
- Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases
- Nattokinase as an adjuvant therapeutic strategy for non-communicable diseases
- Natto and its active ingredient nattokinase: A potent and safe thrombolytic agent
- Navigating the Effects of Anti-Atherosclerotic Supplements and Acknowledging Associated Bleeding Risks
- 機能性食品としての納豆: 血栓溶解酵素ナットウキナーゼとその投与効果
- 降圧効果を持つ機能性食品の薬理作用


